These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6933485)

  • 21. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
    Drachman DB; Angus CW; Adams RN; Kao I
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical properties of junctional and extrajunctional acetylcholine receptor.
    Dwyer DS; Bradley RJ; Furner RL; Kemp GE
    Brain Res; 1981 Jul; 217(1):23-40. PubMed ID: 6167329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor on the surface of TE671 cells.
    Pachner AR
    Neurology; 1989 Aug; 39(8):1057-61. PubMed ID: 2761699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
    Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
    Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
    [No Abstract]   [Full Text] [Related]  

  • 25. Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor.
    Takamori M; Okumura S; Nagata M; Yoshikawa H
    J Neurol Sci; 1988 Jun; 85(2):121-9. PubMed ID: 3260271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sera from myasthenia gravis patients and of alpha-bungarotoxin on acetylcholinesterase during in vitro neuromuscular synaptogenesis.
    de la Porte S; Ragueh F; Eymard B; Courbin P; Chapron J; Koenig J
    J Neurol Sci; 1993 Jul; 117(1-2):92-102. PubMed ID: 8410074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B; Bach JF; Morel E
    Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity.
    Vernet-der Garabedian B; Eymard B; Bach JF; Morel E
    J Neuroimmunol; 1989 Jan; 21(1):41-7. PubMed ID: 2908881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of acetylcholine receptor antibody in relatives of myasthenic patients.
    Walker GL; Nicholson LV; Mastaglia FL
    Lancet; 1980 Apr; 1(8171):778-9. PubMed ID: 6103204
    [No Abstract]   [Full Text] [Related]  

  • 31. Localization of 3H-nicotine, 125I-kappa-bungarotoxin, and 125I-alpha-bungarotoxin binding to nicotinic sites in the chicken forebrain and midbrain.
    Sorenson EM; Chiappinelli VA
    J Comp Neurol; 1992 Sep; 323(1):1-12. PubMed ID: 1430311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies directed against a synthetic peptide corresponding to the alpha-bungarotoxin binding region of the acetylcholine receptor.
    Preston-Hurlburt P; Wilson PT; Dowding AJ; Hawrot E
    Biochim Biophys Acta; 1990 Mar; 1033(3):324-8. PubMed ID: 2317509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TE671 cells express an abundance of a partially mature acetylcholine receptor alpha subunit which has characteristics of an assembly intermediate.
    Conroy WG; Saedi MS; Lindstrom J
    J Biol Chem; 1990 Dec; 265(35):21642-51. PubMed ID: 2254320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin.
    Morel E; Vernet-der Garabedian B; Raimond F; Audhya TK; Goldstein G; Bach JF
    Eur J Immunol; 1987 Aug; 17(8):1109-13. PubMed ID: 3622601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there acetylcholine receptor in human thymus?
    Nicholson GA; Appel SH
    J Neurol Sci; 1977 Oct; 34(1):101-8. PubMed ID: 915531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-ligand antibodies as potential autoantigens: in vitro and in vivo characteristics of anti-bungarotoxin antibodies in the idiotype network.
    Pachner AR; Itano AA; McCallum RM; Ricalton NS
    Autoimmunity; 1991; 10(2):145-52. PubMed ID: 1782327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological and pharmacological heterogeneity of alpha-bungarotoxin binding sites extracted from TE671 cells.
    Walker R; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1988 Aug; 19(1-2):149-57. PubMed ID: 3397405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to the nicotinic acetylcholine receptor, obtained from serum of myasthenic patients, may decrease acetylcholine release from rat hippocampal nerve endings in vitro.
    Heilbronn E; Häggblad J; Kubát B
    Ann N Y Acad Sci; 1981; 377():198-207. PubMed ID: 6951473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.